146 related articles for article (PubMed ID: 15036853)
1. Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.
Rosier JF; Bruniaux M; Husson B; Octave-Prignot M; Beauduin M; Grégoire V
Radiother Oncol; 2004 Jan; 70(1):55-61. PubMed ID: 15036853
[TBL] [Abstract][Full Text] [Related]
2. The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.
Rosier JF; Beauduin M; Bruniaux M; de Bast M; de Coster B; Octave-Prignot M; Scalliet P; Grégoire V
Int J Radiat Biol; 1999 Feb; 75(2):245-51. PubMed ID: 10072186
[TBL] [Abstract][Full Text] [Related]
3. The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
Rosier JF; Michaux L; Ameye G; Cedervall B; Libouton JM; Octave-Prignot M; Verellen-Dumoulin C; Scalliet P; Grégoire V
Mutat Res; 2003 Jun; 527(1-2):15-26. PubMed ID: 12787910
[TBL] [Abstract][Full Text] [Related]
4. Radiation enhancement by gemcitabine-mediated cell cycle modulations.
Mose S; Class R; Weber HW; Rahn A; Brady LW; Böttcher HD
Am J Clin Oncol; 2003 Feb; 26(1):60-9. PubMed ID: 12576927
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.
Grégoire V; Beauduin M; Rosier JF; De Coster B; Bruniaux M; Octave-Prignot M; Scalliet P
Br J Cancer; 1997; 76(10):1315-21. PubMed ID: 9374377
[TBL] [Abstract][Full Text] [Related]
6. [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].
Miao JW; Kong WM; Zhang WH; Niu JW; Deng XH
Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):342-5. PubMed ID: 15196420
[TBL] [Abstract][Full Text] [Related]
7. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines.
Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Damrau M; Ramm U; Rahn A; Böttcher HD
Anticancer Res; 2000; 20(1A):401-5. PubMed ID: 10769687
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between cisplatin and gemcitabine in vitro.
Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Peters GJ
Clin Cancer Res; 1996 Mar; 2(3):521-30. PubMed ID: 9816199
[TBL] [Abstract][Full Text] [Related]
9. [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine].
Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Ramm U; Damrau M; Rahn A; Böttcher HD
Strahlenther Onkol; 1999 Feb; 175(2):78-83. PubMed ID: 10065143
[TBL] [Abstract][Full Text] [Related]
10. Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours.
Ruiz van Haperen VW; Veerman G; Boven E; Noordhuis P; Vermorken JB; Peters GJ
Biochem Pharmacol; 1994 Oct; 48(7):1327-39. PubMed ID: 7945430
[TBL] [Abstract][Full Text] [Related]
11. In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells.
Wouters A; Pauwels B; Lardon F; Pattyn GG; Lambrechts HA; Baay M; Meijnders P; Vermorken JB
BMC Cancer; 2010 Aug; 10():441. PubMed ID: 20723210
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
Santini V; Bernabei A; Gozzini A; Scappini B; Zoccolante A; D'Ippolito G; Figuccia M; Ferrini PR
Haematologica; 1997; 82(1):11-5. PubMed ID: 9172997
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle effects of gemcitabine.
Cappella P; Tomasoni D; Faretta M; Lupi M; Montalenti F; Viale F; Banzato F; D'Incalci M; Ubezio P
Int J Cancer; 2001 Aug; 93(3):401-8. PubMed ID: 11433406
[TBL] [Abstract][Full Text] [Related]
14. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine.
van Haperen VW; Veerman G; Vermorken JB; Pinedo HM; Peters G
Biochem Pharmacol; 1996 Apr; 51(7):911-8. PubMed ID: 8651941
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.
van Moorsel CJ; Bergman AM; Veerman G; Voorn DA; Ruiz van Haperen VW; Kroep JR; Pinedo HM; Peters GJ
Biochim Biophys Acta; 2000 Mar; 1474(1):5-12. PubMed ID: 10699484
[TBL] [Abstract][Full Text] [Related]
17. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.
Grégoire V; Rosier JF; De Bast M; Bruniaux M; De Coster B; Octave-Prignot M; Scalliet P
Radiother Oncol; 2002 Jun; 63(3):329-38. PubMed ID: 12142097
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.
van Bree C; Castro Kreder N; Loves WJ; Franken NA; Peters GJ; Haveman J
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):237-44. PubMed ID: 12182997
[TBL] [Abstract][Full Text] [Related]
19. The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines.
Pauwels B; Korst AE; Pattyn GG; Lambrechts HA; Kamphuis JA; De Pooter CM; Peters GJ; Lardon F; Vermorken JB
BMC Cancer; 2006 May; 6():142. PubMed ID: 16734894
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
van Moorsel CJ; Pinedo HM; Veerman G; Bergman AM; Kuiper CM; Vermorken JB; van der Vijgh WJ; Peters GJ
Br J Cancer; 1999 Jun; 80(7):981-90. PubMed ID: 10362105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
